Welcome to LookChem.com Sign In|Join Free
  • or
Benzo[b]thiophene, 3-[4-(methylsulfonyl)phenyl]-2-phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

178614-24-9

Post Buying Request

178614-24-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

178614-24-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 178614-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,6,1 and 4 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 178614-24:
(8*1)+(7*7)+(6*8)+(5*6)+(4*1)+(3*4)+(2*2)+(1*4)=159
159 % 10 = 9
So 178614-24-9 is a valid CAS Registry Number.

178614-24-9Downstream Products

178614-24-9Relevant academic research and scientific papers

Directed metalation and regioselective functionalization of 3-bromofuran and related heterocycles with NaHMDS

Zhao, Hang,Dankwardt, John W.,Koenig, Stefan G.,Singh, Surendra P.

supporting information; experimental part, p. 166 - 169 (2012/01/30)

A mild and regioselective functionalization protocol for 3-bromofuran and analogs has been developed. Selective metalation and functionalization of C2 can be achieved as a result of the directing effect of the adjacent electron-withdrawing bromo group. In addition, the C5 position can also be selectively functionalized by blocking the C2 position via silylation or by simply controlling the reaction temperature. These functionalized compounds bearing a C3 bromo substituent may be further elaborated by utilizing a Suzuki-Miyaura cross-coupling procedure.

Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 178614-24-9
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer